Rebecca C Obeng

9PUBLICATIONS
41CO-AUTHORS
Molecular targetsBioinformatic methods developmentPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 26, 2025
Efineptakin alfa (NT-I7) improves overall survival and induces tertiary lymphoid structures in murine lung tumors.

Trang Dinh, Judong Lee, Sidra Islam

|Aug 12, 2025
The College of American Pathologists Biorepository Accreditation Program: Results from the First 10 Years.

Nalin Leelatian, Joan H Rose, Sarah Cliff

|Jan 31, 2025
Characterisation of clinical response and transcriptional profiling of proliferating CD8 T cells in the blood of cancer patients after PD-1 monotherapy or combination therapy.

Rebecca C Obeng, Tahseen H Nasti, Kylee Martens

|Feb 10, 2024
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond.

Surya Pandey, Meghan E Cholak, Rishita Yadali

|Sep 28, 2022
PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program.

Masao Hashimoto, Koichi Araki, Maria A Cardenas

|Jan 21, 2022
SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemia.

Cuijuan Han, Alireza Khodadadi-Jamayran, Adam H Lorch

Pageof 2

Frequent Collaborators

4 joint publications

Haydn T Kissick

3 joint publications

Andreas Wieland

3 joint publications

Rafi Ahmed

2 joint publications

William H Hudson